The International Society on Thrombosis and Haemostasis (ISTH) just opened two guidance manuscript drafts to public comment. Management of Thrombotic Risk Associated with Endocrine and Other Systemic Therapy in Patients with Breast Cancer and The Diagnosis and Evaluation of Women and Girls with Hemophilia and Hemophilia Carriers are both open to comment through February 19.
- Click here to review the guidance draft Management of Thrombotic Risk Associated with Endocrine and Other Systemic Therapy in Patients with Breast Cancer.
- Click here to review the guidance draft The Diagnosis and Evaluation of Women and Girls with Hemophilia and Hemophilia Carriers.
Both manuscripts are confidential.
Physicians, scientists, and allied health professionals are free to submit their comments online through February 19. Due to conflict of interest concerns, anonymous comments are not accepted.
- Click here to view the comment submission form for the guidance draft Management of Thrombotic Risk Associated with Endocrine and Other Systemic Therapy in Patients with Breast Cancer.
- Click here to view the comment submission form for the guidance draft The Diagnosis and Evaluation of Women and Girls with Hemophilia and Hemophilia Carriers.
Sign up for alerts to keep up with the latest clinical guidelines and guideline updates.
Copyright © 2026 Guideline Central, all rights reserved.